Success Metrics

Clinical Success Rate
100.0%

Based on 12 completed trials

Completion Rate
100%(12/12)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
6
50%
Ph phase_2
6
50%

Phase Distribution

0

Early Stage

6

Mid Stage

6

Late Stage

Phase Distribution12 total trials
Phase 2Efficacy & side effects
6(50.0%)
Phase 3Large-scale testing
6(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

12 of 12 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

12

all time

Status Distribution
Completed(12)

Detailed Status

Completed12

Development Timeline

Analytics

Development Status

Total Trials
12
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 26 (50.0%)
Phase 36 (50.0%)

Trials by Status

completed12100%

Recent Activity

0 active trials
Showing 5 of 12
completedphase_2

A Long-Term Safety Study of Asoprisnil in the Treatment of Uterine Fibroids.

NCT00156182
completedphase_3

Treatment of Uterine Fibroids With Asoprisnil(J867)

NCT00152269
completedphase_2

A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Women With Endometriosis.

NCT00160433
completedphase_2

A Long-Term Study to Evaluate the Safety of Asoprisnil in the Treatment of Women With Endometriosis From Study M01-398

NCT00160420
completedphase_3

A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Uterine Fibroids

NCT00160381
View all 12 trials

Clinical Trials (12)

Showing 12 of 12 trials
NCT00156182Phase 2

A Long-Term Safety Study of Asoprisnil in the Treatment of Uterine Fibroids.

Completed
NCT00152269Phase 3

Treatment of Uterine Fibroids With Asoprisnil(J867)

Completed
NCT00160433Phase 2

A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Women With Endometriosis.

Completed
NCT00160420Phase 2

A Long-Term Study to Evaluate the Safety of Asoprisnil in the Treatment of Women With Endometriosis From Study M01-398

Completed
NCT00160381Phase 3

A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Uterine Fibroids

Completed
NCT00160459Phase 2

A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Uterine Fibroids

Completed
NCT00150644Phase 2

A Study to Evaluate the Effects of Asoprisnil(J867) in Women With Uterine Fibroids Who Are Scheduled for a Hysterectomy

Completed
NCT00152256Phase 3

A Study to Evaluate of the Safety and Effectiveness of Asoprisnil in Treating Women With Uterine Fibroids

Completed
NCT00156195Phase 3

Study to Evaluate the Safety of Asoprisnil in the Treatment of Uterine Fibroids

Completed
NCT00160446Phase 2

A Study to Evaluate the Safety and Effectiveness of Three Asoprisnil Doses in the Treatment of Women With Endometriosis

Completed
NCT00156208Phase 3

Safety of Treatment of Uterine Fibroids With Asoprisnil

Completed
NCT00156156Phase 3

Study of Asoprisnil in the Treatment of Uterine Fibroids.

Completed

All 12 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
12